Red blood cell transfusion and chemotherapy administration: A study of resource utilization

Community Oncology

Volumn 5, Issue 11, 2008, Pages 598-603

  Minuk, Leonard ^a,b,e   Chin Yee, Ian ^a,b,c   Hibbert, Anita ^a,b   Chan, Daphne ^d   Xenocostas, Anargyros ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c CANADIAN BLOOD SERVICES   (Canada)

^d Medical Affairs   (Canada)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; RITUXIMAB;

ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; DRUG UTILIZATION; ERYTHROCYTE TRANSFUSION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MIXED MYELODYSPLASTIC MYELOPROLIFERATIVE DISEASE; QUALITY OF LIFE; SOLID TUMOR;

EID: 57149106535     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1548-5315(11)70524-1     Document Type: Article

References (18)

1. Lyman GH, Berndt ER, Kallich JD, et al. The economic burden of anemia in cancer patients receiving chemotherapy. Value Health 2005;8:149-156.
2. Wells AW. Who uses blood? Vox Sang 2004;87(suppl 2):S146-S148.
3. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B; Epoetin Alfa Study Group. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001;19:2865-2874.
4. Kurz CH, Marth CH, Windbichler G, et al. Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study. Gynecol Oncol 1997;65:461-466.
5. Henry DH, Brooks BJ Jr, Case DC Jr, et al. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. Cancer J Sci Am 1995;1:252-260.
6. Case DC Jr, Bukowski RM, Carey RW, et al. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 1993;85:801-806.
7. Cascinu S, Fedeli A, Del Ferro E, Luzi Fedeli S, Catalano G. Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo. J Clin Oncol 1994;12:1058-1062.
8. Rizzo JD, Somerfield MR, Hagerty KL, et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update. Blood 2008;111:25-41.
9. Crémieux PY, Barrett B, Anderson K, Slavin MB. Cost of outpatient blood transfusion in cancer patients. J Clin Oncol 2000;18:2755-2761.
10. Agrawal S, Davidson N, Walker M, et al. Assessing the total costs of blood delivery to hospital oncology and haematology patients. Curr Med Res Opin 2006;22:1903-1909.
11. Dranitsaris G. The cost of a unit of red blood cells in Canada: a reanalysis of existing estimates incorporating the absolute risk of bacterial infections following transfusion. American Association of Blood Banks (San Antonio-Poster). October 12-17, 2001.
12. Ortega A, Dranitsaris G, Puodziunas A. A clinical and economic evaluation of red blood cell transfusions in patients receiving cancer chemotherapy. Int J Technol Assess Health Care 1998;14:788-798.
13. Dranitsaris G. The cost of blood transfusion in cancer patients: a re-analysis of a Canadian economic evaluation. J Oncol Pharm Pract 2000;6:1-6.
14. Ueno W, Beveridge RA, Kales AN. Costs of outpatient red blood cell transfusions. J Support Oncol 2006;4:494-495.
15. Ontario Hospital Collective Agreement. Ontario Nurses Association. March 31, 2008;54-59.
16. Ueno W, Beveridge R. Time burden of blood transfusion. Blood 2005;106:3125.
17. Hellström-Lindberg E. Update on supportive care and new therapies: immunomodulatory drugs, growth factors and epigenetic-acting agents. Hematology Am Soc Hematol Educ Program 2005:161-166.
18. Bokemeyer C, Aapro MS, Courdi A, et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer 2007;43:258-270.